CancerPPD

This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.

ID	PMID	SEQUENCE	NAME	LENGTH	ACTIVITY
1053	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=14.7 µg/ml
1054	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=11.3 µg/ml
1055	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=8.2 µg/ml
1056	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=17 µg/ml
1057	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=10.5 µg/ml
1058	18617323	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	IC₅₀=20.2 µg/ml
1141	12005420	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	IC₅₀=20 µM
1142	12005420	KWKFKKIPKFLHLAKKF	P18	17	IC₅₀=4 µM
1143	12005420	KWKLFKKILKFLHLAKKF	[L9]-P18	18	IC₅₀=9 µM
1144	12005420	KWKLFKKISKFLHLAKKF	[S9]-P18	18	IC₅₀=7 µM
1145	12005420	WKLFKKIPKFLHLAKKF	N-1	17	IC₅₀=12 µM
1146	12005420	FKLFKKIPKFLHLAKKF	N-2	17	IC₅₀=11 µM
1147	12005420	KWFKKIPKFLHLAKKF	N-3	16	IC₅₀=17 µM
1148	12005420	WFKKIPKFLHLAKKF	N-4	15	IC₅₀=23 µM
1149	12005420	WKKIPKFLHLAKKF	N-5	14	IC₅₀=100.0 <µM
1150	12005420	KWFKKIPKFLHLLKKF	N-3L	16	IC₅₀=4 µM
1151	12005420	WFKKIPKFLHLLKKF	N-4L	15	IC₅₀=6 µM
1152	12005420	WKKIPKFLHLLKKF	N-5L	14	IC₅₀=14 µM
1153	12005420	KWKLFKKIPFLHLAKKF	C-1	17	IC₅₀=32 µM
1154	12005420	KWKLFKKIPKFLHLAKK	C-2	17	IC₅₀=26 µM
1155	12005420	KWKLFKKIPLHLAKKF	C-3	16	IC₅₀=74 µM
1156	12005420	KWKLFKKIPKFLHLAK	C-4	16	IC₅₀=31 µM
1157	12005420	KWKLFKKIPHLAKKF	C-5	15	IC₅₀=81 µM
1158	12005420	KWKLFKKIPKFLHLA	C-6	15	IC₅₀=21 µM
1159	12005420	KWKLFKKIPLAKKF	C-7	14	IC₅₀=100.0 <µM
1160	12005420	KWKLFKKIPKFLHL	C-8	14	IC₅₀=54 µM
1161	12005420	KWKLFKKIPLKKF	C-9	13	IC₅₀=100.0 <µM
1162	12005420	KWKLFKKIPKFLH	C-10	13	IC₅₀=100.0 <µM
1163	12005420	KWKLFKKIPKFLHSAKKF	CA-MA-P	18	IC₅₀=25 µM
1164	12005420	KWKFKKIPKFLHLAKKF	P18	17	IC₅₀=3.5 µM
1165	12005420	KWKLFKKILKFLHLAKKF	[L9]-P18	18	IC₅₀=3 µM
1166	12005420	KWKLFKKISKFLHLAKKF	[S9]-P18	18	IC₅₀=3 µM
1167	12005420	WKLFKKIPKFLHLAKKF	N-1	17	IC₅₀=6 µM
1168	12005420	FKLFKKIPKFLHLAKKF	N-2	17	IC₅₀=7 µM
1169	12005420	KWFKKIPKFLHLAKKF	N-3	16	IC₅₀=11 µM
1170	12005420	WFKKIPKFLHLAKKF	N-4	15	IC₅₀=24 µM
1171	12005420	WKKIPKFLHLAKKF	N-5	14	IC₅₀=100.0 <µM
1172	12005420	KWFKKIPKFLHLLKKF	N-3L	16	IC₅₀=4.2 µM
1173	12005420	WFKKIPKFLHLLKKF	N-4L	15	IC₅₀=3 µM
1174	12005420	WKKIPKFLHLLKKF	N-5L	14	IC₅₀=10 µM
1175	12005420	KWKLFKKIPFLHLAKKF	C-1	17	IC₅₀=31 µM
1176	12005420	KWKLFKKIPKFLHLAKK	C-2	17	IC₅₀=23 µM
1177	12005420	KWKLFKKIPLHLAKKF	C-3	16	IC₅₀=62 µM
1178	12005420	KWKLFKKIPKFLHLAK	C-4	16	IC₅₀=25 µM
1179	12005420	KWKLFKKIPHLAKKF	C-5	15	IC₅₀=67 µM
1180	12005420	KWKLFKKIPKFLHLA	C-6	15	IC₅₀=27 µM
1181	12005420	KWKLFKKIPLAKKF	C-7	14	IC₅₀=100.0 <µM
1182	12005420	KWKLFKKIPKFLHL	C-8	14	IC₅₀=30 µM
1183	12005420	KWKLFKKIPLKKF	C-9	13	IC₅₀=100.0 <µM
1184	12005420	KWKLFKKIPKFLH	C-10	13	IC₅₀=100.0 <µM
1185	10675500	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	IC₅₀=65 µM
1186	10675500	KWKLFKKIKFLHSAKKF	CA-MA1	17	IC₅₀=85.3 µM
1187	10675500	KWKLFKKIPKFLHSAKKF	CA-MA2	18	IC₅₀=35.1 µM
1188	10675500	KWKLFKKIGPGKFLHSAKKF	CA-MA3	20	IC₅₀=>100 µM
1193	10675500	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	IC₅₀=30 µM
1194	10675500	KWKLFKKIKFLHSAKKF	CA-MA1	17	IC₅₀=65 µM
1195	10675500	KWKLFKKIPKFLHSAKKF	CA-MA2	18	IC₅₀=20 µM
1196	10675500	KWKLFKKIGPGKFLHSAKKF	CA-MA3	20	IC₅₀=75 µM
1231	7849420	KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL	Cecropin B	35	IC₅₀=15.5 µM
1235	7849420	SWLSKTAKKLENSAKKRISEGIAIAIQGGPR	Cecropin P1	31	IC₅₀=93 µM
1239	7849420	MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG	Shiva-1	38	IC₅₀=28.7 µM
1243	7849420	KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL	Cecropin B	35	IC₅₀=4.4 µM
1253	10951191	GLFDIIKKIAESF	Aurein1.2	13	LC₅₀=10-100 µM
1262	10951191	GLFDIVKKVVGAFGSL	Aurein2.5	16	LC₅₀=10-100 µM
1271	10951191	GLFDIAKKVIGVIGSL	Aurein2.6	16	LC₅₀=10-100 µM
1280	10951191	GLFDIVKKIAGHIAGSI	Aurein 3.1	17	LC₅₀ = 10 µM
1289	10951191	GLFDIVKKIAGHIASSI	Aurein 3.2	17	LC₅₀ = 10 µM
1298	10951191	GLFDIVKKIAGHIVSSI	Aurein 3.3	17	LC₅₀=10-100 µM
1352	18425992	FKCRRWQWRMKKLGAPSITCVR	pep1	22	IC₅₀=77 µM
1353	18425992	RKAFRWAWRMLKKAAPSITCVR	mPep1	22	IC₅₀=8 µM
1354	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=17 µg/ml
1355	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=19 µg/ml
1356	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=16 µg/ml
1357	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	IC₅₀=97 µg/ml
1358	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	IC₅₀=123 µg/ml
1359	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >150 µg/ml
1360	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=12 µg/ml
1361	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=16 µg/ml
1362	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=18 µg/ml
1363	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	IC₅₀=60 µg/ml
1364	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	IC₅₀=83 µg/ml
1365	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >150 µg/ml
1366	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=27 µg/ml
1367	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=29 µg/ml
1368	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=23 µg/ml
1369	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	IC₅₀=107 µg/ml
1370	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	IC₅₀=109 µg/ml
1371	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >150 µg/ml
1372	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=28 µg/ml
1373	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=38 µg/ml
1374	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=30 µg/ml
1375	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	IC₅₀=115 µg/ml
1376	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	IC₅₀=143 µg/ml
1377	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >150 µg/ml
1378	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=30 µg/ml
1379	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=33 µg/ml
1380	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=34 µg/ml
1381	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	IC₅₀=80 µg/ml
1382	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	IC₅₀=102 µg/ml
1383	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >150 µg/ml
1384	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=23 µg/ml
1385	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=25 µg/ml
1386	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=20 µg/ml
1387	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	IC₅₀=64 µg/ml
1388	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	IC₅₀=72 µg/ml
1389	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >150 µg/ml
1390	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=32 µg/ml
1391	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=37 µg/ml
1392	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=40 µg/ml
1393	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	IC₅₀=98 µg/ml
1394	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	IC₅₀=112 µg/ml
1395	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >150 µg/ml
1396	1708887, 2285300	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	IC₅₀=32 µg/ml
1397	1708887, 2285300	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	IC₅₀=39 µg/ml
1398	1708887, 2285300	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	IC₅₀=45 µg/ml
1399	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z44	24	Not Available
1400	1708887, 2285300	ALSKALSKALSKALSKALSKALSK	Z24	24	Not Available
1401	1708887, 2285300	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	IC₅₀ >200 µg/ml
1420	8573171, 21403917	TRSSRAGLQFPVGRVHRLLRK	Buforin2	21	5% Cytotoxicity at 0.5 µg/ml
1421	10455241, 21403917	GLFDVIKKVASVIGGL	Citropin1.1	16	60% Cytotoxicity at 0.5 µg/ml
1422	10504394, 21403917	GLFDVIKKVASVIGGL	Citropin1.1	16	60% Cytotoxicity at 0.5 µg/ml
1423	16512752, 21403917	AKRHHGYKRKFH	Demegen P-113	12	15% Cytotoxicity at 0.5 µg/ml
1424	14508884, 21403917	ILRWPWWPWRRK	OmigaNAn MBI-226	12	27% Cytotoxicity at 0.5 µg/ml
1425	7768152, 21403917	GIGKFLKKAKKFGKAFVKILKK	PexigaNAn MSI-78	22	75% Cytotoxicity at 0.5 µg/ml
1426	8335113, 21403917	RGGRLCYCRRRFCVCVGR	Protegrin 1	18	61% Cytotoxicity at 0.5 µg/ml
1427	9022710	FLPLIGRVLSGIL	Temporin A	13	15% Cytotoxicity at 0.5 µg/ml
1430	16269280	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	LD₅₀=30 µM
1431	16269280	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	LD₅₀=1-4 µM
1649	11835991	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	IC₅₀=15.3 µg/ml
1650	11835991	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	IC₅₀=11.4 µg/ml
1651	11835991	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	IC₅₀=24.2 µg/ml
1652	11835991	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	IC₅₀=34.4 µg/ml
1653	11835991	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	IC₅₀=24.3 µg/ml
1654	11835991	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	IC₅₀ =25.2 µg/ml
1655	11835991	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	IC₅₀ =53.4 µg/ml
1656	11835991	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	IC₅₀ >50 µg/ml
2822	23000474	RRRRRNWMWC	9R	10	IC₅₀=93 µM
2823	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=38 µM
2824	23000474	RRRRRNWMWC	9R	10	IC₅₀=39 µM
2825	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=43 µM
2826	23000474	RRRRRNWMWC	9R	10	IC₅₀=37 µM
2827	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=43 µM
2828	23000474	RRRRRNWMWC	9R	10	IC₅₀=36 µM
2829	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=45 µM
2830	23000474	RRRRRNWMWC	9R	10	IC₅₀=25 µM
2831	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=36 µM
2832	23000474	RRRRRNWMWC	9R	10	IC₅₀=47 µM
2833	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=26 µM
2834	23000474	RRRRRNWMWC	9R	10	IC₅₀=12 µM
2835	23000474	RRRRRWCMNW	9S1R	10	IC₅₀=17 µM
2842	24246647	GIIKKIIKKI	Short α-helical peptides	10	100% Cytotoxicity at 5 µM Approx
2843	24246647	GIIKKIIKKIIKKI	Short α-helical peptides	14	90% Cytotoxicity at 5 µM Approx
2844	24246647	GIIKKIIKKIIKKIIKKI	Short α-helical peptides	18	70% Cytotoxicity at 5 µM Approx
2850	23028527	GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV	Adenoregulin	33	GI₅₀ =2.57±0.75 µM
3072	16004618	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Not Available
3073	16004618	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	IC₅₀= 50 µM
3074	16004618	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	IC₅₀= 29 µM
3075	16004618	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	IC₅₀= 67 µM
3076	16004618	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	IC₅₀= 50 µM
3077	16004618	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	IC₅₀= >70 µM
3078	16004618	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	IC₅₀= >70 µM
3079	16004618	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	IC₅₀= 53 µM
3080	16004618	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	IC₅₀= 20 µM
3081	16004618	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	IC₅₀= 52 µM
3082	16004618	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	IC₅₀=51 µM
3083	16004618	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	IC₅₀= >70 µM
3084	16004618	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	IC₅₀=>70 µM
3085	16004618	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	IC₅₀= 47 µM
3086	16004618	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	IC₅₀= 23 µM
3087	16004618	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	IC₅₀= 50 µM
3088	16004618	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	IC₅₀= 46 µM
3089	16004618	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	IC₅₀=>70 µM
3104	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	100% cell viability at 5 µM
3105	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	<40% cell viability at 50 µM
3110	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	100% cell viability at 5 µM
3111	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	<60% cell viability at 50 µM
3157	23301519	WRWRWRWRW	Cyclic [W(RW)4 ]-Dox	9	62-73% inhibition of cell proliferation at 1 µM
3161	23301519	RWRWRWRW	linear (RW)4-Dox	8	46-69% antiproliferative activity at 1 µM
3180	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	10.4 % inhibition of cell proliferation at 1 nM
3181	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	18.7 % inhibition of cell proliferation at 10 nM
3182	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	34.7 % inhibition of cell proliferation at 100 nM
3183	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	54.3 % inhibition of cell proliferation at 1 µM
3184	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	94.5 % inhibition of cell proliferation at 10 µM
3188	17559067	fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL	Peptide 5	40	ED₅₀ =0.29 µM
3256	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	100% cell viability at 5 µM
3257	22783018	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	<40% cell viability at 50 µM
3262	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	100% cell viability at 5 µM
3263	22783018	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	<60% cell viability at 50 µM
3283	19527490, 23533710	FKCRRWQWRMKK	LfcinB	12	IC₅₀ = 55 µM
3286	19527490, 23533710	FKCRRWQWRMKK	LfcinB	12	IC₅₀ = 13 µM
3287	19527490, 23533710	FKCRRWQWRMKK	LfcinB	12	IC₅₀ = 10 µM
3345	22820149	Structure Given	BAA-1	Not Available	IC₅₀ = 8.1 µg/ml
3346	22820149	Structure Given	BAA-2	Not Available	IC₅₀ = 3.8 µg/ml
3352	None	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	100% survival rate at 10 µM
3353	None	KWKLFKKIGIGKFLHSAKKF	CA-MA	20	0% survival rate at 100 µM
3358	None	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	~60% survival rate at 10 µM
3359	None	KWKKLLKKPPPLLKKLLKKL	Synthetic peptide	20	0% survival rate at 100 µM
3545	22100226	VNWKKILGKIIKVVK	LL-III	15	IC₅₀ = 5±3 µM
3546	22100226	VNWKKILAKIIKVVK	LL-III/1	15	IC₅₀ = 3±1 µM
3547	22100226	NVWKKILGKIIKVVK	LL-III/2	15	IC₅₀ = 7±2 µM
3548	22100226	VNWKKILKKIIKVVK	LL-III/3	15	Not tested
3549	22100226	VNWKKILGKIKKVVK	LL-III/4	15	IC₅₀ = 18 µM
3550	22100226	VNWKKILPKIIKVVK	LL-III/6	15	IC₅₀ = 6±3 µM
3551	22100226	VNWKKILGKIIKVVK	LL-III/8	15	IC₅₀ = 9 µM
3552	22100226	VNWKKILGKIIKVVK	LL-III/9	15	Not tested
3553	22100226	KNWKKILGKIIKVVK	LL-III/10	15	IC₅₀ = 9 µM
3554	22100226	VNWKKIILGKIIKVVK	LL-III/11	15	IC₅₀ = 4±1 µM
3555	22100226	vnwkkilgkiikvvk	LL-III/12	15	IC₅₀ = 5±2 µM
3556	22100226	VNFKKLLGKLLKVVK	LL-III/15	15	IC₅₀ = 9±3 µM
3557	22100226	VN-Nal-KKLLGKLLKVVK	LL-III/16	15	Not tested
3558	22100226	VNWRRILGRIIRVVR	LL-III/17	15	Not tested
3559	22100226	KNWKKILKKIIKVVK	LL-III/18	15	IC₅₀ = 7±2 µM
3560	22100226	VNWKK-Aib-LGK-Aib-IK-Aib-VK	LL-III/19	15	IC₅₀ = 8±2 µM
3561	22100226	KNWKK-Aib-LKK-Aib-IK-Aib-VK	LL-III/22	15	IC₅₀ = 25±4 µM
3562	22100226	VNWKKLLGKLLKVVK	LL-III/23	15	IC₅₀ = 6 µM
3563	22100226	VNWOOILGOIIOVVO	LL-III/24	15	IC₅₀ = 5±2 µM
3564	22100226	vnwkkllgkllkvvk	LL-III/25	15	IC₅₀ = 4 µM
3565	22100226	VYWKKILGKIIKVVK	LL-III/26	15	IC₅₀ = 6 µM
3566	22100226	VNWKKVLGKVVKVVK	LL-III/27	15	IC₅₀ = 18 µM
3567	22100226	NKWKKILGKIIKVVK	LL-III/34	15	IC₅₀ = 5±3 µM
3568	22100226	VNWKKILAKIIKVVK	LL-III/36	15	Not tested
3569	22100226	VNWKKILGKIIKVVK	LL-III/37	15	IC₅₀= 4±1 µM
3618	22100226	GFGMALKLLKKVL	MAC1	13	IC₅₀ = 12±6 µM
3619	22100226	GTGLPMSERRKIMLMMR	MAC2	17	IC₅₀ = 32 µM
3620	22100226	gfgmalkllkkvl	MAC1/1	13	IC₅₀ = 11 µM
3621	22100226	AFGMALKLLKKVL	MAC1/2	13	IC₅₀ = 17 µM
3622	22100226	LFGMALKLLKKVL	MAC1/3	13	IC₅₀ = 22 µM
3623	22100226	GFGMALKLLKKVL	MAC1/4	13	IC₅₀ = 29 µM
3624	22100226	GFGMALKLLKKVL	MAC1/6	13	IC₅₀ = 15 µM
3625	22100226	GFKMALKLLKKVL	MAC1/9	13	IC₅₀ = 14±4 µM
3626	22100226	GFKMALKLLKKVL	MAC1/10	13	IC₅₀ = 16 µM
3627	22100226	GFGMALKLLKKVL	MAC1/16	13	IC₅₀ = 70 µM
3628	22100226	GFGMALKLLKKVL	MAC1/19	13	IC₅₀ = 43±11 µM
3629	22100226	GFGMALOLLOOVL	MAC1/20	13	IC₅₀ = 25±3 µM
3630	22100226	GFGMALRLLRRVL	MAC1/21	13	IC₅₀ = 22±4 µM
3631	22100226	GFGMALKL-(AC6C)-KKVL	MAC1/24	13	IC₅₀ = 11 µM
3632	22100226	GFGMALK-(AC6C)-LKKVL	MAC1/25	13	IC₅₀ = 12±2 µM
3633	22100226	GFGMA-(AC6C)-KLLKKVL	MAC1/26	13	IC₅₀ = 9±2 µM
3690	22100226	GMWSKILGHLIR	HAL-1	12	IC₅₀ = 49±9 µM
3691	22100226	gmwskilghlir	HAL-1/22	12	Not tested
3692	22100226	GMWSKILGHLIK	HAL-1/6	12	Not tested
3693	22100226	GMWSKILGHLKR	HAL-1/4	12	Not tested
3694	22100226	GMWSKILGKLIR	HAL-1/9	12	IC₅₀ = 30±10 µM
3695	22100226	GMWSKILKHLIR	HAL-1/18	12	Not tested
3696	22100226	GMWKKILGHLIR	HAL-1/5	12	IC₅₀ > 40 µM
3697	22100226	GKWSKILGHLIR	HAL-1/12	12	IC₅₀ > 40 µM
3698	22100226	KMWSKILGHLIR	HAL-1/17	12	Not tested
3699	22100226	GMWKKILGKLIR	HAL-1/10	12	Not tested
3700	22100226	GKWSKILGKLIR	HAL-1/20	12	IC₅₀ > 40 µM
3701	22100226	GKWKKILGHLIR	HAL-1/19	12	Not tested
3702	22100226	GKWKKILGKLIR	HAL-1/21	12	Not tested
3703	22100226	GMWSKILGHLIR	HAL-1/29	12	Not tested
3704	22100226	GMWSKLLGHLLR	HAL-1/15	12	IC₅₀ > 40 µM
3705	22100226	GKWMSLLKHILK	HAL-2	12	IC₅₀ = 34 µM
3706	22100226	gkwmsllkhilk	HAL-2/22	12	Not tested
3707	22100226	GKWMSLLKKILK	HAL-2/4	12	Not tested
3708	22100226	GKWMKLLKHILK	HAL-2/2	12	IC₅₀ > 40 µM
3709	22100226	GKWKSLLKHILK	HAL-2/1	12	IC₅₀ > 40 µM
3710	22100226	GKWMSLLKHILK	HAL-2/8	12	Not tested
3711	22100226	GKWMSLLKHIWK	HAL-2/18	12	Not tested
3712	22100226	GKWMSLLKHWLK	HAL-2/19	12	Not tested
3713	22100226	GKWMSLWKHILK	HAL-2/20	12	Not tested
3714	22100226	GKFMSLLKHILK	HAL-2/24	12	Not tested
3715	22100226	GKWMSFLKHILK	HAL-2/6	12	Not tested
3716	22100226	GKWMTLLKHILK	HAL-2/13	12	Not tested
3717	22100226	GKWLSLLKHILK	HAL-2/11	12	Not tested
3718	24176852	YGRKKRRQRRRREADFFWSLCTADMS	KilerFLIP	26	NA
3719	2387772	I-C28H46N4O6, II-C27H44N4O6, III-C26H42N4O6	Cepafungin complex	Not Available	NA
3773	22933412	KKWβ2,2WKK	c1	7	IC₅₀= 10±2 µMol/L
3774	22933412	KW β2,2WKK	c2	6	IC₅₀= 7.9±0.3 µMol/L
3775	22933412	KK β2,2WKK	c3	6	IC₅₀= 15±2 µMol/L
3776	22933412	KW β2,2KK	c4	5	IC₅₀= 12.6±0.6 µMol/L
3777	22933412	KKW β2,2WKK	c5	7	IC₅₀= 11±2 µMol/L
3778	22933412	KW β2,2WKK	c6	6	IC₅₀= 8±1 µMol/L
3779	22933412	KK β2,2WKK	c7	6	IC₅₀= 16±5 µMol/L
3780	22933412	KW β2,2KK	c8	5	IC₅₀= 20±2 µMol/L
3781	22933412	KKWβ2,2WKK	c1	7	IC₅₀= 22±5 µMol/L
3782	22933412	KW β2,2WKK	c2	6	IC₅₀= 1.71±0.6 µMol/L
3783	22933412	KK β2,2WKK	c3	6	IC₅₀= 92±2 µMol/L
3784	22933412	KW β2,2KK	c4	5	IC₅₀= 99±15 µMol/L
3785	22933412	KKW β2,2WKK	c5	7	IC₅₀= 23±3 µMol/L
3786	22933412	KW β2,2WKK	c6	6	IC₅₀= 26±2 µMol/L
3787	22933412	KK β2,2WKK	c7	6	IC₅₀= 157±30 µMol/L
3788	22933412	KW β2,2KK	c8	5	IC₅₀= 226±21 µMol/L
4030	12631273, 9266696	GLFDVIKKVASVIGGL	Citropin 1.1	16	IC₅₀= 5 M
4039	12631273, 9266696	glfdvikkvasviggl	Citropin 1.1D	16	IC₅₀= 5 M
4048	12631273, 9266696	GLFAVIKKVASVIGGL	3	16	IC₅₀= 6 M
4057	12631273, 9266696	GLFDVIKAVASVIGGL	5	16	IC₅₀= 5 M
4066	12631273, 9266696	GLFDVIKKVAAVIGGL	7	16	IC₅₀= 5 M
4075	12631273, 9266696	GLFDVIKKVASVIKGL	11	16	IC₅₀= 5 M
4084	12631273, 9266696	GLFDVIKKVASVIKKL	13	16	IC₅₀= 5 M
4093	12631273, 9266696	GLFDVIAKVASVIKKL	14	16	IC₅₀= 5 M
4102	12631273, 9266696	GLFAVIKKVASVIKGL	15	16	IC₅₀= 5 M
4111	12631273, 9266696	GLFAVIKKVASVIKKL	16	16	IC₅₀= 5 M
4120	12631273, 9266696	GLFAVIKKVAAVIKKL	17	16	IC₅₀= 5 M
4129	12631273, 9266696	GLFAVIKKVAAVIRRL	18	16	IC₅₀= 5 M
4138	12631273, 9266696	GLFAVIKKVAKVIKKL	19	16	IC₅₀= 5 M
4147	12631273, 9266696	GLFKVIKKVASVIGGL	22	16	IC₅₀= 5 M
4156	12631273, 9266696	GLFKVIKKVAKVIKKL	23	16	IC₅₀= 5 M
4165	12631273, 9266696	LGGIVSAVKKIVDFLG	retro	16	IC₅₀= 5 M
4199	15835725	lw	Psychrophilin D (1)	Not Available	ID₅₀=10.1 µg/ml
4208	15875779, 1429232	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	No inhibition at 4 µM
4209	15875779, 1429232	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	No inhibition at 4 µM
4210	15875779, 1429232	Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG	Laxaphycin A	12	No inhibition at 4 µM
4211	15875779, 1429232	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	50% inhibition at 1 µM
4212	15875779, 1429232	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	44% inhibition at 1 µM
4213	15875779, 1429232	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	44% inhibition at 1 µM
4214	15875779, 1429232	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	44% inhibition at 1 µM
4215	15875779, 1429232	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	40% inhibition at 1 µM
4216	15875779, 1429232	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	40% inhibition at 1 µM
4217	15875779, 1429232	A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu	Laxaphycin B	13	40% inhibition at 1 µM
4469	22076954	IELLQARGGC-Pem	Peptide-1	10	IC₅₀ = 2.17 µM
4470	22076954	IELLQARGGC-Pem-GGRRRRRRRR	Peptide-2	10	IC₅₀ = 2.64 µM
4471	22076954	RRRRRRRRGGC-Pem	Peptide-3	11	IC₅₀ = 6.24 µM
4592	21403917	TRSSRAGLQFPVGRVHRLLRK	Buforin 2	21	IC₅₀ =90-95 µg/ml
4593	21403917	GLFDVIKKVASVIGGL	Citropin 1.1	16	IC₅₀ =40 µg/ml
4594	21403917	AKRHHGYKRKFH	Demegen P-113	12	IC₅₀ =85-90 µg/ml
4595	21403917	ILRWPWWPWRRK	Omiganan MBI-226	12	IC₅₀ =80-85 µg/ml
4596	21403917	GIGKFLKKAKKFGKAFVKILKK	Pexiganan MSI-78	18	IC₅₀ =20-30 µg/ml
4597	21403917	RGGRLCYCRRRFCVCVGR	Protegrin 1	18	IC₅₀ =30-40 µg/ml
4598	21403917	FLPLIGRVLSGIL	Temporin A	13	IC₅₀ =80-90 µg/ml
4611	20802991	CSSRTMHHC	Peptide-20	9	at 100 µM 90% viablity
4640	8445676	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	IC₅₀=.00013-.0013 nM
4641	8445676	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	IC₅₀=.00013-.0013 nM
4642	8445676	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	IC₅₀=.00013-.0013 nM
4643	8445676	VV-Nme-VPP-2-hydroxyisovaleryl-2- oxo-4-methoxy-5-benzyl-3-pyrroline	Dolastatin 15	Not Available	IC₅₀=.00013-.0013 nM
4644	8445676	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	IC₅₀=.0013-.013 nM
4645	8445676	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	IC₅₀=.0013-.013 nM
4646	8445676	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	IC₅₀=.00013-.0013 nM
4647	8445676	2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N- [3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1- (1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin- 1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3- dimethylbutanamide	Dolastatin 10	Not Available	IC₅₀=.0013-.013 nM
4648	23085771	Not Available	5a	3	IC₅₀=10.6 µM
4649	23085771	Not Available	5b	3	IC₅₀=7.1 µM
4650	23085771	Not Available	5c	3	IC₅₀=4.1 µM
4651	23085771	Not Available	6a	3	IC₅₀=14.4 µM
4652	23085771	Not Available	6b	3	IC₅₀=11.0 µM
4653	23085771	Not Available	6c	3	IC₅₀=4.3 µM
4654	23085771	Not Available	7a	3	IC₅₀=>63 µM
4655	23085771	Not Available	7b	3	IC₅₀=>78 µM
4656	23085771	Not Available	7c	3	IC₅₀=79 µM
4657	23085771	Not Available	8a	3	IC₅₀=136 µM
4658	23085771	Not Available	8b	3	IC₅₀=>254 µM
4659	23085771	Not Available	8c	3	IC₅₀=107 µM
4660	23085771	Not Available	9a	3	IC₅₀=31 µM
4661	23085771	Not Available	9b	3	IC₅₀=2.3 µM
4662	23085771	Not Available	9c	3	IC₅₀=3.1 µM
4663	23085771	Not Available	10a	3	IC₅₀=28 µM
4664	23085771	Not Available	10b	3	IC₅₀=11.4 µM
4665	23085771	Not Available	10c	3	IC₅₀=6.6 µM
4666	23085771	Not Available	11a	3	IC₅₀=5.2 µM
4667	23085771	Not Available	11b	3	IC₅₀=19 µM
4668	23085771	Not Available	11c	3	IC₅₀=7.2 µM
4669	23085771	Not Available	12a	3	IC₅₀=6.1 µM
4670	23085771	Not Available	12b	3	IC₅₀=27 µM
4671	23085771	Not Available	12c	3	IC₅₀=14 µM

CancerPPD :Database of Anticancer peptides and Proteins

Browse Result page of CancerPPD